AU2002212102A1 - A process for production of particles for pharmaceutical compositions having increased bioavailability - Google Patents
A process for production of particles for pharmaceutical compositions having increased bioavailabilityInfo
- Publication number
- AU2002212102A1 AU2002212102A1 AU2002212102A AU1210202A AU2002212102A1 AU 2002212102 A1 AU2002212102 A1 AU 2002212102A1 AU 2002212102 A AU2002212102 A AU 2002212102A AU 1210202 A AU1210202 A AU 1210202A AU 2002212102 A1 AU2002212102 A1 AU 2002212102A1
- Authority
- AU
- Australia
- Prior art keywords
- particles
- production
- pharmaceutical compositions
- increased bioavailability
- bioavailability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70796600A | 2000-11-08 | 2000-11-08 | |
US09/707,966 | 2000-11-08 | ||
PCT/DK2001/000715 WO2002038126A2 (en) | 2000-11-08 | 2001-10-29 | A process for production of particles for pharmaceutical compositions having increased bioavailability |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002212102A1 true AU2002212102A1 (en) | 2002-05-21 |
Family
ID=24843867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002212102A Abandoned AU2002212102A1 (en) | 2000-11-08 | 2001-10-29 | A process for production of particles for pharmaceutical compositions having increased bioavailability |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002212102A1 (en) |
WO (1) | WO2002038126A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10026698A1 (en) | 2000-05-30 | 2001-12-06 | Basf Ag | Self-emulsifying active ingredient formulation and use of this formulation |
US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
DE10355461A1 (en) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases |
WO2005115330A2 (en) * | 2004-05-28 | 2005-12-08 | Pfizer Products Inc. | Pharmaceutical compositions with enhanced performance |
DK1773816T3 (en) | 2004-06-24 | 2015-01-26 | Vertex Pharma | Modulators of ATP-binding cassette transporters |
JP5409010B2 (en) | 2005-12-28 | 2014-02-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | Solid form of N- [2,4-bis (1,1-dimethylethyl) -5-hydroxyphenyl] -1,4-dihydro-4-oxoquinoline-3-carboxamide |
NZ624460A (en) | 2009-03-20 | 2015-12-24 | Vertex Pharma | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
EP2579896B1 (en) | 2010-06-14 | 2016-07-20 | Dow Global Technologies LLC | Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
US9084727B2 (en) | 2011-05-10 | 2015-07-21 | Bend Research, Inc. | Methods and compositions for maintaining active agents in intra-articular spaces |
CN104470518A (en) | 2012-02-27 | 2015-03-25 | 沃泰克斯药物股份有限公司 | Pharmaceutical composition and administration thereof |
CA2963945C (en) | 2014-10-07 | 2023-01-10 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2528706B2 (en) * | 1988-05-30 | 1996-08-28 | ゼリア新薬工業株式会社 | Pharmaceutical composition of dihydropyridine compound |
GB9114374D0 (en) * | 1991-07-03 | 1991-08-21 | Smithkline Beecham Plc | Novel process |
DK0741603T3 (en) * | 1994-01-27 | 1999-08-23 | Aeromatic Fielder Ag | Apparatus for coating solid particles |
US5910319A (en) * | 1997-05-29 | 1999-06-08 | Eli Lilly And Company | Fluoxetine enteric pellets and methods for their preparation and use |
EP0901786B1 (en) * | 1997-08-11 | 2007-06-13 | Pfizer Products Inc. | Solid pharmaceutical dispersions with enhanced bioavailability |
US6209479B1 (en) * | 1998-12-30 | 2001-04-03 | Aeromatic-Fielder Ag | Apparatus for coating tablets |
-
2001
- 2001-10-29 AU AU2002212102A patent/AU2002212102A1/en not_active Abandoned
- 2001-10-29 WO PCT/DK2001/000715 patent/WO2002038126A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2002038126A3 (en) | 2002-10-10 |
WO2002038126A2 (en) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001288175A1 (en) | A process for the production of paper | |
AU2001258276A1 (en) | Process for the production of a deodorant or antiperspirant product | |
AU2002220968A1 (en) | Process for the preparation of a fast dissolving dosage form | |
AU2002352353A1 (en) | Process for production of styrene | |
AU2002212102A1 (en) | A process for production of particles for pharmaceutical compositions having increased bioavailability | |
AU6487600A (en) | Process for production of an etheralcohol | |
AU2002354109A1 (en) | Process for production of methionine | |
AU2464401A (en) | Process for the preparation of oligomeric compounds | |
AU2002356755A1 (en) | Process for production of detergent tablets | |
AU2001240664A1 (en) | Process for the production of methionine | |
AU2001277545A1 (en) | Process for the production of 2-hydroxy-4-methylmercaptobutyric acid | |
IL160193A0 (en) | Process for the preparation of a 14-hydroxynormorphinone derivative | |
AU2002353366A1 (en) | The process of manufacturing a pharmaceutical composition useful for management of cancer | |
AU2566100A (en) | Process for the production of a nutritional composition | |
AU2003212351A1 (en) | A process for the preparation of cephalosporan acid derivatives from cephalosporin c | |
AU2001274586A1 (en) | Process for producing phospholipid-containing drugs | |
AU2002310898A1 (en) | Process for the preparation of a polymer-amine | |
AU2002308986A1 (en) | Process for preparation of a quinolinecarbaldehyde | |
HK1060733A1 (en) | Method for the production of a stable pharmaceutical form of paclitaxel | |
AU2002302767A1 (en) | Process for the preparation of a particulate material | |
AUPQ916700A0 (en) | A method of preparing a pharmaceutical composition | |
AU2001264231A1 (en) | Process for the preparation of a piperazine derivative | |
AU2002352423A1 (en) | Process for the manufacture of pharmaceutically acceptable salts of a compound | |
AU2001248965A1 (en) | The process for the production of a packing material | |
AU2001279511A1 (en) | Process for obtaining a pharmaceutical composition |